Equities analysts predict that CME Group Inc (NASDAQ:CME) will announce earnings of $1.63 per share for the current quarter, Zacks reports. Four analysts have issued estimates for CME Group’s earnings. The highest EPS estimate is $1.83 and the lowest is $1.57. CME Group posted earnings of $1.74 per share in the same quarter last year, which would indicate a negative year-over-year growth rate of 6.3%. The firm is expected to report its next quarterly earnings results on Thursday, July 25th.
According to Zacks, analysts expect that CME Group will report full-year earnings of $6.62 per share for the current financial year, with EPS estimates ranging from $6.42 to $6.92. For the next year, analysts anticipate that the business will post earnings of $7.34 per share, with EPS estimates ranging from $7.02 to $7.62. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side research analysts that follow CME Group.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.60 by $0.02. The business had revenue of $1.18 billion for the quarter, compared to analyst estimates of $1.19 billion. CME Group had a net margin of 42.47% and a return on equity of 9.29%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the business posted $1.86 EPS.
CME has been the topic of several analyst reports. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a research report on Thursday, January 31st. Sanford C. Bernstein reiterated an “outperform” rating and set a $210.00 price target on shares of CME Group in a research report on Friday, February 15th. JPMorgan Chase & Co. initiated coverage on shares of CME Group in a research report on Friday, February 15th. They set an “underweight” rating and a $164.00 price target on the stock. Citigroup set a $205.00 price target on shares of CME Group and gave the stock a “buy” rating in a research report on Friday, February 15th. Finally, Deutsche Bank reduced their price target on shares of CME Group from $220.00 to $214.00 and set a “buy” rating on the stock in a research report on Friday, March 15th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $189.71.
In other news, insider Kathleen M. Cronin sold 8,340 shares of the firm’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $167.54, for a total transaction of $1,397,283.60. Following the completion of the transaction, the insider now owns 41,604 shares of the company’s stock, valued at $6,970,334.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jeffrey M. Bernacchi sold 10,087 shares of the firm’s stock in a transaction on Tuesday, February 26th. The shares were sold at an average price of $177.94, for a total transaction of $1,794,880.78. Following the transaction, the director now directly owns 42,004 shares of the company’s stock, valued at approximately $7,474,191.76. The disclosure for this sale can be found here. Insiders sold 38,489 shares of company stock worth $6,739,196 in the last 90 days. Company insiders own 1.20% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the company. Sheaff Brock Investment Advisors LLC raised its stake in CME Group by 0.3% during the fourth quarter. Sheaff Brock Investment Advisors LLC now owns 22,040 shares of the financial services provider’s stock worth $4,146,000 after buying an additional 60 shares during the last quarter. Dorsey & Whitney Trust CO LLC raised its stake in CME Group by 1.4% during the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 4,575 shares of the financial services provider’s stock worth $860,000 after buying an additional 65 shares during the last quarter. Berman Capital Advisors LLC raised its stake in CME Group by 23.9% during the first quarter. Berman Capital Advisors LLC now owns 342 shares of the financial services provider’s stock worth $56,000 after buying an additional 66 shares during the last quarter. Dubuque Bank & Trust Co. raised its stake in CME Group by 83.1% during the first quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock worth $25,000 after buying an additional 69 shares during the last quarter. Finally, Front Barnett Associates LLC raised its stake in CME Group by 5.4% during the fourth quarter. Front Barnett Associates LLC now owns 1,433 shares of the financial services provider’s stock worth $267,000 after buying an additional 73 shares during the last quarter. 84.78% of the stock is owned by hedge funds and other institutional investors.
NASDAQ CME opened at $183.29 on Thursday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.16. The company has a market cap of $65.23 billion, a P/E ratio of 26.88, a PEG ratio of 4.17 and a beta of 0.32. CME Group has a 1 year low of $157.21 and a 1 year high of $197.08.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 10th will be given a $0.75 dividend. The ex-dividend date of this dividend is Friday, June 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.64%. CME Group’s dividend payout ratio is currently 43.99%.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Recommended Story: Trading Ex-Dividend Strategy
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.